ProfileGDS5822 / ILMN_2822621
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 96% 96% 95% 97% 95% 95% 96% 96% 96% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 11591.496
GSM1276600PDAC Late Ablation Control 21470.296
GSM1276601PDAC Late Ablation Control 31420.895
GSM1276602PDAC Late Ablation 11661.997
GSM1276603PDAC Late Ablation 21338.495
GSM1276604PDAC Late Ablation 31299.695
GSM1303940PDAC Late Ablation_anti-CTLA4 11595.196
GSM1303941PDAC Late Ablation_anti-CTLA4 21720.596
GSM1303942PDAC Late Ablation_anti-CTLA4 31674.296